These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 341433)

  • 1. B peripheral lymphocytes express more HLA antigens than T peripheral lymphocytes.
    Pellegrino MA; Belvedere M; Pellegrino AG; Ferrone S
    Transplantation; 1978 Feb; 25(2):93-5. PubMed ID: 341433
    [No Abstract]   [Full Text] [Related]  

  • 2. Alpha-interferon induces enhanced expression of HLA-ABC antigens and beta-2-microglobulin in vivo and in vitro in various subsets of human lymphoid cells.
    Nissen MH; Larsen JK; Plesner T; Olesen BK; Ernst P
    Clin Exp Immunol; 1987 Sep; 69(3):632-8. PubMed ID: 2959413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitation of beta2-microglobulin and HLA on the surface of human cells. I. T and B lymphocytes and lymphoblasts.
    Dorval G; Welsh KI; Nilsson K; Wigzell H
    Scand J Immunol; 1977; 6(4):255-63. PubMed ID: 67632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactivity of cold agglutinins with subsets of human lymphocytes of various origins.
    Pruzanski W; Armstrong M; Ko H; Norman C; Minta J
    Haematologia (Budap); 1982 Dec; 15(4):409-18. PubMed ID: 6764629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of anti-HLA antibody using small-dose single-donor blood transfusion.
    Ettenger R; Cho S; Marik J; von Lilien T; Fine RN
    Transplant Proc; 1987 Feb; 19(1 Pt 1):740-2. PubMed ID: 3274859
    [No Abstract]   [Full Text] [Related]  

  • 6. Differential expression of HLA class-I antigens on B and T lymphocytes obtained from human lymphoid tissues.
    Bishara A; Nelken D; Brautbar C
    Immunobiology; 1988 Apr; 177(1):76-81. PubMed ID: 3260212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement and cell-mediated specific destruction of human endothelial cells treated with anti-DRw antisera.
    Hirschberg H; Moen T; Thorsby E
    Transplant Proc; 1979 Mar; 11(1):776-8. PubMed ID: 377711
    [No Abstract]   [Full Text] [Related]  

  • 8. HLA-DRw alloantigens can be detected on peripheral blood T lymphocytes.
    Mann DL; Sharrow SO
    J Immunol; 1980 Nov; 125(5):1889-96. PubMed ID: 7000892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MHC class I and class I-like gene product expression by malignant T cells: relationships between CD1a, HLA-ABC and beta 2-microglobulin.
    Jones RA; Scott CS; Katz FE; Child JA
    Clin Exp Immunol; 1988 Dec; 74(3):454-8. PubMed ID: 2466592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dilutions and specificity analysis of pretransplant sera.
    Iwaki Y; Terasaki PI; Park MS; Heintz R; Silberman H; Berne T
    Transplant Proc; 1979 Mar; 11(1):944-9. PubMed ID: 377726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic factors influencing pregnancy.
    Gall SA
    Obstet Gynecol Annu; 1985; 14():25-44. PubMed ID: 3885093
    [No Abstract]   [Full Text] [Related]  

  • 12. Rapid turnover of HLA proteins in quiescent lymphocytes: proposed connection with immunologic surveillance.
    Monos DS; Cooper HL
    J Immunol; 1983 Jul; 131(1):341-6. PubMed ID: 6345664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of new cell surface markers in man: the problem of immunogenicity.
    Ferrara GB
    Transplant Proc; 1979 Mar; 11(1):715-8. PubMed ID: 313101
    [No Abstract]   [Full Text] [Related]  

  • 14. Enhancement by interferon of membrane HLA antigens in patients with combined immunodeficiency with defective HLA expression.
    Durandy A; Virelizier JL; Griscelli C
    Clin Exp Immunol; 1983 Apr; 52(1):173-8. PubMed ID: 6190592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antigenic signal to immunocompetent cells].
    Marx A
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1985; 30(1):1-12. PubMed ID: 3159067
    [No Abstract]   [Full Text] [Related]  

  • 16. Serologic and genetic aspects of HLA-DR antigen study.
    Curtoni ES; Borelli I; Carbonara AO; Diotallevi P; Olivetti E; Neri TM; Savi M
    Transplant Proc; 1979 Jun; 11(2):1317-8. PubMed ID: 89735
    [No Abstract]   [Full Text] [Related]  

  • 17. Enhancement of reactivity of HLA-Cw antisera by extending the incubation time.
    Wong DM; Kumar R; Mittal KK
    Acta Anthropogenet; 1983; 7(3):197-203. PubMed ID: 6335043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of circulating maternal T and B lymphocytes in uncomplicated severe combined immunodeficiency by HLA typing of subpopulations of T cells separated by the fluorescence-activated cell sorter and of Epstein Barr virus-derived B cell lines.
    Geha RS; Reinherz E
    J Immunol; 1983 Jun; 130(6):2493-5. PubMed ID: 6304187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extra reactivities detected in flow-cytometry-positive, CDC-negative crossmatches are definable HLA specificities.
    Rodey G; Bollig B; Oldfather J; Schutte L; Flye W; Phelan D
    Transplant Proc; 1987 Feb; 19(1 Pt 1):778-9. PubMed ID: 3274872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of DR antigens on human T lymphoid cells: serologic and immunochemical studies with xenoantisera.
    Wilson BS; Indiveri F; Pellegrino MA; Ferrone S
    Transplant Proc; 1979 Mar; 11(1):712-4. PubMed ID: 377706
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.